|
mRNA_ID
|
Gene Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
lung adenocarcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
hcc
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
ewing sarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
esophageal squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
esophageal squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
esophageal squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
lung squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
hepatoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
hepatoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
medulloblastoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
hcc
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
cervical cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
esophageal squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
melanoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
cervical cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
head and neck squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
melanoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
bladder cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
endometrial cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
diffuse large b cell lymphoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
melanoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
glioblastoma multiforme (gbm)
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
oral squamous cell cancer (oscc)
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
glioblastoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
glioma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
chondrosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
leukemia
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
cervical cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
squamous esophageal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
cholangiocarcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
laryngeal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
laryngeal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
liver cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
liver cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
gallbladder cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
salivary adenoid cystic carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB05098
|
Leptin
|
lung injury
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
PD-161570
|
intestinal inflammatory disorder
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB17042
|
PD-98059
|
intestinal inflammatory disorder
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB04835
|
Maraviroc
|
HIV-associated neurological complications
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
Oncostatin M
|
intestinal inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
AG-1295
|
lung disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB04339
|
Carbocisteine
|
chronic obstructive pulmonary disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB00482
|
Celecoxib
|
vascular remodeling
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB12003
|
Thymosin beta-4
|
periodontitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB12003
|
Thymosin beta-4
|
inflammatory osteolytic disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB00331
|
Metformin
|
pancreatic ductal adenocarcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
Heqi San
|
polycystic ovary syndrome
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
17α-Ethinylestradiol
|
cholestasis
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB00254
|
Doxycycline
|
abdominal aortic aneurysm
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB12290
|
Puerarin
|
coronary artery disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB00254
|
Doxycycline
|
atrial fibrillation
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB04868
|
Nilotinib
|
chronic myelogenous leukemia
|
up-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
JSI287
|
cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
Compound musk injection
|
ischemic stroke
|
up-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB14038
|
beta-Sitosterol
|
idiopathic pulmonary fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB16288
|
Peoniflorin
|
idiopathic pulmonary fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
NA
|
Duhuo Jisheng decoction
|
neuropathic pain
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB14122
|
Dihydroxymethoxychalcone
|
degenerative disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB04216
|
Quercetin
|
endometriosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB01645
|
Genistein
|
ovarian cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3
|
DB12025
|
triptolide
|
interstitial lung disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000263025
|
MAPK3 (ERK1)
|
NA
|
Enterolactone
|
breast cancer
|
down-regulated
|
validated
|
more...
|